Kailera Kailera
  • About
  • Science
  • Programs
  • Team
  • News
  • Contact
  • Join Us
Select Page

Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of a Novel Oral Small Molecule GLP-1 Receptor Agonist (HRS-7535) in Healthy Subjects: A Phase 1, Randomized, Double-blind, Placebo-controlled, Single- and Multiple-Ascending Dose (SAD and MAD) Study

by thaan@22fillmore | Jun 9, 2023

  • Privacy Policy
  • Terms of Use
©2025 Kailera Therapeutics.

Website by 22 Fillmore

©2025 Kailera Therapeutics.
  • Privacy Policy
  • Terms of Use

Website by 22 Fillmore